Your session is about to expire
← Back to Search
Behavioural Intervention
Virtual Reality for Chronic Pain Management
N/A
Recruiting
Led By Jennifer Stinson, RN, PhD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aged 12-18 years old
Diagnosed with chronic pain
Must not have
Diagnosis of seizure disorder, history of seizure, or increased risk of seizure
Currently receiving sedating medications
Timeline
Screening 3 weeks
Treatment Varies
Follow Up reported verbally to pt pre-, during (10 minutes from the start of their session), and post- each pt session - through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trialwill investigate if virtual reality can help teens with chronic pain manage their symptoms better than standard video treatments. #painrehabilitation #virtualreality
Who is the study for?
This trial is for teens aged 12-18 with chronic pain, who can speak and read English, are under care at a specific clinic, have stable medication/therapy, can move safely on their own, need at least 4 virtual physiotherapy sessions, and have internet access. It's not for those with seizure risks, major untreated mental illnesses or personality disorders, VR intolerance (like nausea), recent headaches/migraines or concussions.
What is being tested?
The study tests if virtual reality programs designed for pain rehabilitation are user-friendly and effective in improving pain management and physical function in teens during COVID-19 compared to standard videoconference physiotherapy. Teens' experiences will be evaluated through questionnaires and interviews.
What are the potential side effects?
While the trial itself does not involve medications that typically cause side effects, some participants may experience discomfort from using VR such as eye strain or motion sickness.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 12 and 18 years old.
Select...
I have been diagnosed with chronic pain.
Select...
I can move around on my own and safely do physical activities.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a seizure disorder or a history of seizures.
Select...
I am currently taking medication that makes me sleepy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ reported verbally to pt pre-, during (10 minutes from the start of their session), and post- each pt session - through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~reported verbally to pt pre-, during (10 minutes from the start of their session), and post- each pt session - through study completion, an average of 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability/Satisfaction
Outcome measure feasibility
Participant Accrual
+5 moreSecondary study objectives
Exercise intensity
Fear of movement
Pain
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Off the Shelf VR (PR-VR program + usual care)Experimental Treatment1 Intervention
* One session per week x 4 weeks; total 4 sessions over 1 month
* PR-VR program (30 min) + Usual care (30 min SVPT)
* Total intervention time = 4 hours
* 10 selected for post-study telephone interview
Group II: Custom VR (Modified PR-VR program + usual care)Experimental Treatment1 Intervention
* One session per week x 4 weeks; total 4 sessions over 1 month
* Mod PR-VR program (30 min) + Usual care (30 min SVPT)
* Total intervention time = 4 hours
* 10 selected for post-study telephone interview
Group III: Standard Virtual Physiotherapy Treatment (control; usual care),Active Control1 Intervention
* One session per week x 4 weeks; total 4 sessions over 1 month
* Usual care (60 min SVPT)
* Total intervention time = 4 hours
Find a Location
Who is running the clinical trial?
The Hospital for Sick ChildrenLead Sponsor
712 Previous Clinical Trials
6,959,326 Total Patients Enrolled
8 Trials studying Chronic Pain
987 Patients Enrolled for Chronic Pain
Stanford UniversityOTHER
2,489 Previous Clinical Trials
17,516,951 Total Patients Enrolled
39 Trials studying Chronic Pain
9,949 Patients Enrolled for Chronic Pain
Jennifer Stinson, RN, PhDPrincipal InvestigatorThe Hospital for Sick Children
3 Previous Clinical Trials
140 Total Patients Enrolled
1 Trials studying Chronic Pain
60 Patients Enrolled for Chronic Pain
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 12 and 18 years old.I have been diagnosed with chronic pain.My medication for pain has not changed in the last week.I have new or worsening headaches, motion sickness, nausea, vomiting, or possible concussion symptoms.You have a serious untreated mental illness, like depression, anxiety, or PTSD.I need to attend at least 4 virtual physical therapy sessions.I can move around on my own and safely do physical activities.You feel very uncomfortable in small spaces or have had a bad experience with virtual reality in the past.I can access the internet with a smart device for weekly health visits.I have a seizure disorder or a history of seizures.I am currently taking medication that makes me sleepy.
Research Study Groups:
This trial has the following groups:- Group 1: Custom VR (Modified PR-VR program + usual care)
- Group 2: Standard Virtual Physiotherapy Treatment (control; usual care),
- Group 3: Off the Shelf VR (PR-VR program + usual care)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.